Medtech lobbying group AdvaMed releases a new study on industry pricing, arguing that medical devices represent a consistently small share of total healthcare spending in the U.S.
Medical device makers have long faced intense pricing pressure from customers and scrutiny from policy-makers, but an ongoing industry study suggests that medtech has for years been a minor factor in the growing cost of U.S. care.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1lvVbLQ
Cap comentari:
Publica un comentari a l'entrada